对周期性发烧综合征和自身炎症性疾病的治疗方法
Angel A Herrera Guerra1, Victoria R Dimitriades1
1Division of Pediatric Allergy, Immunology & Rheumatology, University of California Davis Health, 2516 Stockton Boulevard, Sacramento, CA 95818, USA.
Immunology and allergy clinics of North America
|April 26, 2025
概括
本综述讨论了自身炎症性疾病,重点关注周期性发烧综合征和免疫系统调节障碍. 了解IL-1和TNF等细胞因子通路是治疗慢性炎症的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 炎症性疾病的发病因子
背景情况:
- 自身炎症性疾病涉及免疫系统的调节受损,导致慢性炎症.
- 了解炎症途径的最新进展为治疗提供了新的治疗点.
研究的目的:
- 为了审查经典的周期性发烧综合征.
- 讨论与失调的炎症途径相关的疾病,包括IL-1,TNF,NF-kb和1型干扰素.
主要方法:
- 关于经典周期性发烧综合征的文献综述.
- 讨论免疫系统的组成部分和炎症途径.
主要成果:
- 周期性发烧综合征是自身炎症性疾病的一个关键组.
- 特定细胞因子通路 (IL-1,TNF,NF-kb,1型干扰素) 的调节失调是各种自身炎症状况的基础.
结论:
- 有效管理自身炎症性疾病需要针对特定的炎症途径.
- 对细胞因子失调的进一步研究可以为免疫力受损的患者改善治疗策略.
相关概念视频
Autoimmune Disorders
313
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
313
Methods of reducing fever
611
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
611
Inflammatory Bowel Disease IV: Pharmacological Management
79
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
79
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
100
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
100
Inflammatory Response
1.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.6K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97


